Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease

Molecular Psychiatry

Volumn 10, Issue 11, 2005, Pages 1026-1036

  Sweet, R A ^a,b   Devlin, B ^a   Pollock, B G ^a   Sukonick, D L ^a   Kastango, K B ^a   Bacanu, S A ^a   Chowdari, K V ^a   DeKosky, S T ^a   Ferrell, R E ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Alzheimer; Alzheimer disease; Genetic; Geriatric; Psychosis

Indexed keywords

CATECHOL METHYLTRANSFERASE; ESTROGEN; METHIONINE; VALINE;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CODON; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTROGEN RESPONSIVE ELEMENT; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PSYCHOSIS; SCHIZOPHRENIA; SEX DIFFERENCE;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; BASE SEQUENCE; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; DNA; FEMALE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; PSYCHOTIC DISORDERS; RISK FACTORS; VARIATION (GENETICS);

EID: 27544481729     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/sj.mp.4001709     Document Type: Article

References (69)

1. Sweet RA, Nimgaonkar VL, Devlin B, Jeste DV. Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotype. Mol Psychiatry 2003; 8: 383-392.
2. Sweet RA, Nimgaonkar VL, Devlin B, Lopez OL, DeKosky ST. Increased familial risk of the psychotic phenotype of Alzheimer disease. Neurology 2002; 58: 907-911.
3. Bacanu SA, Devlin B, Chowdari KV, DeKosky ST, Nimgaonkar VL, Sweet RA. Heritability of psychosis in Alzheimer disease. Am J Geriatr Psychiatry 2005; 13: (in press).
4. Bacanu SA, Devlin B, Chowdari KV, DeKosky ST, Nimgaonkar VL, Sweet RA. Linkage analysis of Alzheimer disease with psychosis. Neurology 2002; 59: 118-120.
5. Go RC, Perry RT, Weiner H, Bassett SS, Blacker D, Devlin BJ et al. Neuregulin-1 polymorphism in LOAD with psychosis in the NIMH AD sibling families. Neurobiol Aging 2004; 25: 488.
6. Sweet RA, Nimgaonkar VL, Kamboh MI, Lopez OL, Zhang F, DeKosky ST. Dopamine receptor genetic variation, psychosis, and aggression in Alzheimer's disease. Arch Neurol 1998; 55: 1335-1340.
7. Holmes C, Arranz MJ, Powell JF, Collier D, Lovestone S. 5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease. Hum Mol Genet 1998; 7: 1507-1509.
8. Sweet RA, Pollock BG, Sukonick DL, Mulsant BH, Rosen J, Klunk WE et al. The 5-HTTPR polymorphism confers liability to a combined phenotype of psychotic and aggressive behavior in Alzheimer's disease. Int Psychogeriatr 2001; 13: 401-409.
9. Sweet RA, Panchalingam K, Pettegrew JW, McClure RJ, Hamilton RL, Lopez OL et al. Psychosis in Alzheimer disease: postmortem magnetic resonance spectroscopy evidence of excess neuronal and membrane phospholipid pathology. Neurobiol Aging 2002; 23: 547-553.
10. Drevets WC, Rubin EH. Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type. Biol Psychiatry 1989; 25: 39-48.
11. Lopez OL, Wisniewski SR, Becker JT, Boller F, DeKosky ST. Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease. Arch Neurol 1999; 56: 1266-1272.
12. Levy ML, Cummings J, Fairbanks LA, Bravi D, Calvani M, Carta A. Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease. Am J Psychiatry 1996; 153: 1438-1443.
13. Ballard CG, O'Brien JT, Coope B, Wilcock G. Psychotic symptoms in dementia and the rate of cognitive decline. J Am Geriatr Soc 1997; 45: 1031-1032.
14. Paulsen JS, Salmon DP, Thal L, Romero R, Weisstein-Jenkins C, Galasko D et al. Incidence of and risk factors for hallucinations and delusions in patients with probable Alzheimer's disease. Neurology 2000; 54: 1965-1971.
15. Grossman MH, Emanuel BS, Budarf ML. Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1-q11.2. Genomics 1992; 12: 822-825.
16. Carlson C, Sirotkin H, Pandita R, Goldberg R, McKie J, Wadey R et al. Molecular definition of 22q11 deletions in 151 velo-cardiofacial syndrome patients. Am J Hum Genet 1997; 61: 620-629.
17. Lachman HM, Morrow B, Shprintzen R, Veit S, Parsia SS, Faedda G et al. Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. Am J Med Genet 1996; 67: 468-472.
18. Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999; 56: 940-945.
19. Axelrod J, Tomchick R. Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem 1958; 233: 702-705.
20. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996; 6: 243-250.
21. Glatt SJ, Faraone SV, Tsuang MT. Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. Am J Psychiatry 2003; 160: 469-476.
22. Shifman S, Bronstein MSM, Pisante-Shalom A, Lev-Lehman E, Weizman A, Reznik I et al. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 2002; 71: 1296-1302.
23. Driscoll MD, Sathya G, Muyan M, Klinge CM, Hilf R, Bambara RA. Sequence requirements for estrogen receptor binding to estrogen response elements. J Biol Chem 1998; 273: 29321-29330.
24. Xie T, Ho SL, Ramsden D. Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol Pharmacol 1999; 56: 31-38.
25. Lopez OL, Becker JT, Klunk WE, Saxton J, Hamilton RL, Kaufer DI et al. Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades. I. Neurology 2000; 55: 1854-1862.
26. Lopez OL, Becker JT, Klunk WE, Saxton J, Hamilton RL, Kaufer D et al. Research evaluation and diagnosis of possible Alzheimer's disease over the last two decades. II. Neurology 2000; 55: 1863-1869.
27. Mulsant BH, Mazumdar S, Pollock BG, Sweet RA, Rosen J, Lo K. Methodological issues in characterizing treatment response in demented patients with behavioral disturbances. Int J Geriatr Psychiatry 1996; 12: 537-547.
28. Cook SE, Miyahara S, Bacanu SA, Perez-Madrinan G, Lopez OL, Kaufer DI et al. Psychotic symptoms in Alzheimer disease: evidence for subtypes. Am J Geriatr Psychiatry 2003; 11: 406-413.
29. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34: 939-944.
30. Auer SR, Monteiro IM, Reisberg B. The empirical behavioral pathology in Alzheimer's disease (E-BEHAVE-AD) rating scale. Int Psychogeriatr 1996; 8: 247-266.
31. Tariot PN, Mack JL, Patterson MB, Edland SD, Weiner MF, Fillenbaum G, et al., Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease. The behavior rating scale for dementia of the Consortium to Establish a Registry for Alzheimer's Disease. Am J Psychiatry 1995; 152: 1349-1357.
32. Perez-Madrinan G, Cook SE, Saxton JA, Miyahara S, Lopez OL, Kaufer DI et al. Alzheimer disease with psychosis: excess cognitive impairment is restricted to the misidentification subtype. Am J Geriatr Psychiatry 2004; 12: 449-456.
33. Kinnear C, Niehaus DJ, Seedat S, Moolman-Smook JC, Corfield VA, Mahherke G et al. Obsessive-compulsive disorder and a novel polymorphism adjacent to the oestrogen response element (ERE6) upstream from the COMT gene. Psychiatr Genet 2001; 11: 85-87.
34. Chen X, Levine L, Kwok PY. Fluorescence polarization in homogeneous nucleic acid analysis. Genome Res 1999; 9: 492-498.
35. Seltman H, Roeder K, Devlin B. Evolutionary-based association analysis using haplotype data. Genet Epidemiol 2003; 25: 48-58.
36. Templeton AR, Boerwinkle E, Sing CF. A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping. I. Basic theory and an analysis of alcohol dehydrogenase activity in Drosophila. Genetics 1987; 117: 343-351.
37. Templeton AR, Sing CF, Kessling A, Humphries S. A cladistic analysis of phenotype associations with haplotypes inferred from restriction endonuclease mapping. II. The analysis of natural populations. Genetics 1988; 120: 1145-1154.
38. Templeton AR, Crandall KA, Sing CF. A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping and DNA sequence data. III. Cladogram estimation. Genetics 1992; 132: 619-633.
39. Templeton AR, Sing CF. A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping. IV. Nested analyses with cladogram uncertainty and recombination. Genetics 1993; 134: 659-669.
40. Haviland MB, Ferrell RE, Sing CF. Association between common alleles of the low-density lipoprotein receptor gene region and interindividual variation in plasma lipid and apolipoprotein levels in a population-based sample from Rochester, Minnesota. Hum Genet 1997; 99: 108-114.
41. Keavney B, McKenzie CA, Connell JM, Julier C, Ratcliffe PJ, Sobel E et al. Measured haplotype analysis of the angiotensin-I converting enzyme gene. Hum Mol Genet 1998; 7: 1745-1751.
42. Soubrier F, Martin S, Alonso A, Visvikis S, Tiret L, Matsuda F et al. High-resolution genetic mapping of the ACE-linked QTL influencing circulating ACE activity. Eur J Hum Genet 2002; 10: 553-561.
43. Tzeng JY. Evolutionary-based grouping of haplotypes in association analysis. Genet Epidemiol 2005; 28: 220-231.
44. Crandall KA, Templeton AR. Empirical tests of some predictions from coalescent theory with applications to intraspecific phylogeny reconstruction. Genetics 1993; 134: 959-969.
45. Kehoe P, Wavrant-De Vrieze F, Crook R, Wu WS, Holmans P, Fenton I et al. A full genome scan for late onset Alzheimer's disease. Hum Mol Genet 1999; 8: 237-245.
46. Blacker D, Bertram L, Saunders AJ, Moscarillo TJ, Albert MS, Wiener H et al. Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum Mol Genet 2003; 12: 23-32.
47. Pericak-Vance MA, Gaskell PC, Yamaoka LH, Gaskell PC, Scott WK, Terwedow HA et al. Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA 1997; 278: 1237-1241.
48. Pericak-Vance MA, Grubber J, Bailey LR, Hedges D, West S, Santoro L et al. Identification of novel genes in late-onset Alzheimer's disease. Exp Gerontol 2000; 35: 1343-1352.
49. Borroni B, Agosti C, Archetti S, Costanzi C, Bonomi S, Ghianda D et al. Catechol-O-methyltransferase gene polymorphism is associated with risk of psychosis in Alzheimer Disease. Neurosci Lett 2004; 370: 127-129.
50. Bray NJ, Buckland PR, Williams NM, Williams HJ, Norton N, Owen MJ et al. A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am J Hum Genet 2003; 73: 152-161.
51. Handoko HY, Nyholt DR, Hayward NK, Nertney DA, Hannah DE, Windus LC et al. Separate and interacting effects within the catechol-O-methyltransferase (COMT) are associated with schizophrenia. Mol Psychiatry 2004; 10: 589-597.
52. Chen JS, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S et al. Functional analysis of genetic variation in catechol-o-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 2004; 75: 807-821.
53. Matsumoto M, Weickert CS, Beltaifa S, Kolachana B, Chen JS, Hyde TM et al. Catechol O-methyltransferase (COMT) mRNA expression in the dorsolateral prefrontal cortex of patients with schizophrenia. Neuropsychopharmacology 2003; 28: 1521-1530.
54. Tunbridge E, Burnet PWJ, Sodhi MS, Harrison PJ. Catechol-o- methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression. Synapse 2004; 51: 112-118.
55. Chen X, Wang X, O'Neill AF, Walsh D, Kendler KS. Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families. Mol Psychiatry 2004; 9: 962-967.
56. DeMille MM, Kidd JR, Ruggeri V, Palmatier MA, Goldman D, Odunsi A et al. Population variation in linkage disequilibrium across the COMT gene considering promoter region and coding region variation. Hum Genet 2002; 111: 521-537.
57. Worda C, Sator MO, Schneeberger CS, Jantschev T, Ferlitsch K, Huber JC. Influence of the catechol-O-methyltransferase (COMT) codon 158 polymorphism on estrogen levels in women. Hum Reprod 2003; 18: 262-266.
58. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 2001; 98: 6917-6922.
59. Bilder RM, Volavka J, Czobor P, Malhotra AK, Kennedy JL, Ni X et al. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol Psychiatry 2002; 52: 701-707.
60. Jeste DV, Finkel SI. Psychosis of Alzheimer's disease and related dementias. Am J Geriatr Psychiatry 2000; 8: 29-34.
61. Stern Y, Mayeux R, Sano M, Hauser WA, Bush T. Predictors of disease course in patients with probable Alzheimer's disease. Neurology 1987; 37: 1649-1653.
62. Jeste DV, Wragg RE, Salmon DP, Harris MJ, Thal LJ. Cognitive deficits of patients with Alzheimer's disease with and without delusions. Am J Psychiatry 1992; 149: 184-189.
63. Rockwell E, Jackson E, Vilke G, Jeste DV. A study of delusions in a large cohort of Alzheimer's disease patients. Am J Geriatr Psychiatry 1994; 2: 157-164.
64. Lopez OL, Kamboh MI, Becker JT, Kaufer DI, DeKosky ST. The apolipoprotein E ε4 allele is not associated with psychiatric symptoms or extrapyramidal signs in probable Alzheimer's disease. Neurology 1997; 49: 794-797.
65. Lopez OL, Becker JT, Brenner RP, Rosen J, Bajulaiye OI, Reynolds CF. Alzheimer's disease with delusions and hallucinations: neuropsychological and electroencephalographic correlates. Neurology 1991; 41: 906-912.
66. Shifman S, Bronstein M, Sternfeld M, Pisante A, Weizman A, Reznik I et al. COMT: a common susceptibility gene in bipolar disorder and schizophrenia. Am J Med Genet B-Neuropsychiatr Genet 2004; 128B: 61-64.
67. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-989.
68. Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73: 1162-1169.
69. Devlin B, Risch N. A Comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 1995; 29: 311-322.